Latest News

Track Chairs' Top Picks
ESMO Election: 2020-2021
24 May 2017 EMA Completes an Arbitration Procedure for Dexrazoxane Palliative and supportive care
22 May 2017 EMA Adopts a New Indication for Ceritinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 May 2017 FDA Grants Approval to Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
16 May 2017 ESMO - EIU Report on Shortages of Inexpensive, Essential Cancer Medicines Bioethics, legal and economic issues
Registration
11 May 2017 NICE Issues Technology Appraisal Guidance for Pegylated Liposomal Irinotecan Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 May 2017 ESMO 2017 Young Oncologists Track – our biggest track to date!
09 May 2017 Patient Guide in Glioma Now Available Also in Spanish
04 May 2017 ELCC 2017 News: Prospective Study Shows Good Concordance of EGFR Mutation Detection Between ctDNA and Tumour Samples Lung and other thoracic tumours
06 May 2017 ELCC 2017 News: Ensartinib Demonstrates CNS Activity in ALK-positive NSCLC Patients Lung and other thoracic tumours - Anticancer agents & Biologic therapy
06 May 2017 ELCC 2017 News: Specific Immune Cell Profiles Tackle on Tumour Immune Escape and Potentially Identify Lung Cancer Patients Responsive to Anti-PD-1 Immunotherapy Cancer Immunology and Immunotherapy
06 May 2017 ELCC 2017 News: Development and Validation of Outcome Prediction Models Aids Effective Use of Radiotherapy in NSCLC Lung and other thoracic tumours